Results 171 to 180 of about 636,170 (221)

Recent development of BTK-based dual inhibitors in the treatment of cancers

European Journal of Medicinal Chemistry, 2022
Chi Meng, Jianqiang Qian, Yong Ling
exaly  

BTK INHIBITORS

2023
MA BIN, HOPKINS BRIAN T, MARX ISAAC, SCHULZ JÜRGEN, VANDEVEER GEORGE, PRINCE ROBIN, NEVALAINEN MARTA, CHEN TEYU, YOUSAF ZAIN, CAPACCI ANDREW GEORGE   +9 more
  +7 more sources

Next-generation Bruton’s Tyrosine Kinase (BTK) Inhibitors Potentially Targeting BTK C481S Mutation- Recent Developments and Perspectives

Current Topics in Medicinal Chemistry, 2022

exaly  

Non-Covalent BTK Inhibitors—The New BTKids on the Block for B-Cell Malignancies

Journal of Personalized Medicine, 2021
Chan Yoon Cheah, Katharine L Lewis
exaly  

BTK Inhibitors and Chemoimmunotherapy for CLL

Clinical Lymphoma Myeloma and Leukemia, 2020
openaire   +2 more sources

BTK inhibitors

2015
LIU JIAN, KIM RONALD M, KOZLOWSKI JOSEPH, GUIADEEN DEODIALSINGH, KRIKORIAN ARTO D, YU YOUNONG   +5 more
openaire   +5 more sources

Drug-drug interactions and dose management of BTK inhibitors when initiating nirmatrelvir/ritonavir (paxlovid) based on physiologically-based pharmacokinetic models

European Journal of Pharmaceutical Sciences, 2023
Lixian LI, Wanyi Chen
exaly  

BTK inhibitors

2014
WU HAO, KIM RONALD M, LIU JIAN, LIU SHILAN, YANG CHUNDAO, ZHENG SHULING   +5 more
openaire   +5 more sources

Development of BTK inhibitors for the treatment of B-cell malignancies

Archives of Pharmacal Research, 2019
Hyung-Ook Kim
exaly  

BTK INHIBITORS

2022
MA BIN, HOPKINS BRIAN, MARX ISAAC, SCHULZ JÜRGEN, VANDEVEER GEORGE, PRINCE ROBIN, NEVALAINEN MARTA, CHEN TE YU, YOUSAF ZAIN, HIMMELBAUER MARTIN, PATTAROPONG VATEE, JONES JOHN, GILFILLAN RAB, LIN EDWARD, GONZALEZ LOPEZ DE TURISO FELIX   +14 more
openaire   +1 more source